What is hyperandrogenemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Hyperandrogenemia?

Hyperandrogenemia is an endocrine disorder characterized by excessive levels of androgens (male hormones like testosterone) in women, typically caused by overproduction from the ovaries, adrenal glands, or both. 1

Clinical Definition and Pathophysiology

Hyperandrogenemia represents elevated circulating androgen levels that drive the clinical syndrome of "hyperandrogenism"—the visible manifestations of androgen excess. The condition is fundamentally an endocrine disorder where excessive androgen production occurs primarily from:

  • Ovarian sources (most common)
  • Adrenal glands
  • Combined ovarian and adrenal hypersecretion
  • Rarely: abnormal androgen receptor mechanisms or peripheral steroid metabolism 1

The disorder affects 5-10% of reproductive-age women, with polycystic ovary syndrome (PCOS) being the most common underlying cause 1, 2.

Clinical Manifestations

Dermatologic Features

The pilosebaceous unit (PSU) manifestations include:

  • Hirsutism: excessive terminal hair growth in male-pattern distribution (most common presentation) 1, 3
  • Acne: particularly when persistent beyond teenage years, resistant to standard dermatologic treatment, or associated with menstrual irregularities 1
  • Androgenic alopecia: male-pattern hair loss 1

Reproductive System Effects

  • Menstrual dysfunction (amenorrhea, oligomenorrhea, menorrhagia)
  • Anovulation or oligo-ovulation
  • Infertility
  • Ovarian cysts 1

Metabolic and Cardiovascular Complications

Hyperandrogenemia is a forerunner of serious long-term health problems including:

  • Insulin resistance and type 2 diabetes mellitus
  • Dyslipidemias (low HDL cholesterol, elevated triglycerides)
  • Hypertension and microvascular disease
  • Increased cardiovascular risk 1

These metabolic features constitute the "dysmetabolic syndrome" (syndrome X), requiring at least 2 of the following: dyslipidemia, insulin resistance/diabetes, obesity, or hypertension 1.

Psychological Impact

The visible manifestations (cystic acne, hirsutism, alopecia) can have devastating psychosocial effects in young women, including:

  • Severe anxiety and depression
  • Social withdrawal and reduced self-esteem
  • Impaired development of social skills
  • Symptoms resembling premenstrual syndrome (dysphoria) 1

Diagnostic Approach

Biochemical Assessment

Total testosterone assay is the recommended first-line test 4. Key diagnostic thresholds:

  • Testosterone >2× upper limit of normal: Perform DHEAS assay to differentiate adrenal vs. ovarian sources 4
  • DHEAS >600 μg/dL: Suggests androgen-secreting adrenal adenoma 4
  • Normal DHEAS with elevated testosterone: Consider ovarian hyperthecosis (often with insulin resistance) or ovarian tumor 4

Important caveat: Normal testosterone levels do not exclude hyperandrogenism in women with clear clinical symptoms (hirsutism, acne). SHBG is typically reduced with obesity, metabolic syndrome, or family history of diabetes, which can mask elevations in total testosterone while free testosterone remains elevated 4.

Clinical Red Flags

  • Sudden onset and rapid progression of symptoms
  • Virilization (clitoromegaly, deepening voice, increased muscle mass)
  • These features suggest androgen-secreting tumors requiring urgent imaging 1, 5

Clinical Significance

Early recognition and treatment are critical because:

  1. Symptoms often begin in early adolescence but may not be evaluated until late teens or 20s 1
  2. Timely intervention can prevent serious complications with acne, hirsutism, dysfunctional bleeding, and infertility 1
  3. Long-term metabolic and cardiovascular complications may be ameliorated with early treatment 1

The condition requires evaluation of not just the primary presenting symptom but comprehensive assessment of metabolic status, cardiovascular risk factors, and psychological well-being to optimize long-term outcomes 1.

References

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Research

Hyperandrogenaemia and the ovary.

Molecular and cellular endocrinology, 2002

Research

Diagnosis of hyperandrogenism: clinical criteria.

Best practice & research. Clinical endocrinology & metabolism, 2006

Guideline

recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Related Questions

What laboratory evaluation and management should be recommended for perimenopausal patients with suspected androgen excess or menstrual irregularity?
In a 36-year-old woman with hyperandrogenism (elevated testosterone) and polycystic ovary syndrome, what are the possible causes and recommended treatment options?
Can hyperandrogenism in a child cause scalp hair thinning?
In a post‑hysterectomy female patient presenting with hirsutism, what laboratory androgen panel, imaging studies, and treatment plan should be used to evaluate and manage possible hyperandrogenism?
Why does hyperandrogenemia occur in a 6‑year‑old child?
What is the recommended management for a patient who has been receiving albumin infusions for three days and now has mild ascites in the right iliac fossa and pelvis with hepatic congestion?
Does taking a combined oral contraceptive pill (estrogen‑progestin) during early pregnancy increase the risk of congenital heart disease in the fetus?
In a female patient on dialysis who cannot tolerate ibuprofen or acetaminophen, what is the appropriate next step for pain management?
Why is a renal biopsy indicated in a patient presenting with hematuria?
For a pregnant patient with asthma, is daily fluticasone nasal spray (Flonase) appropriate, or should she be treated with an inhaled corticosteroid/long‑acting β2‑agonist combination such as budesonide/formoterol (Symbicort)?
What management steps are recommended for a patient who develops severe gastric cramping the morning after a glucagon‑like peptide‑1 (GLP‑1) receptor agonist injection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.